Brief: Insmed Provides Business Update At 43Rd Annual J.P. Morgan Healthcare Conference
Jan 10 (Reuters) - Insmed Inc INSM.O :
* INSMED PROVIDES BUSINESS UPDATE AT 43RD ANNUAL J.P. MORGAN
HEALTHCARE CONFERENCE
* INSMED INC: NARROWING TIMING FOR EXPECTED U.S. LAUNCH FOR
BRENSOCATIB IN BRONCHIECTASIS TO Q3 OF 2025
* INSMED INC: 2025 GLOBAL ARIKAYCE REVENUES EXPECTED TO BE
BETWEEN
$405 MILLION AND $425 MILLION
Source text: urn:newsml:reuters.com:*:nPn7hX1hwa
Further company coverage: INSM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insmed
See all newsAstera Labs, CoreWeave and others rise after Nasdaq-100 inclusion
U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle
U.S. RESEARCH ROUNDUP- Adobe, Allstate, Teleflex
Brief: Insmed Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- CAVA Group, Eagle Materials, Vertiv Holdings